Cite
HARVARD Citation
Curran, D. et al. (2018). Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States. Vaccine. 36 (33), pp. 5037-5045. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Curran, D. et al. (2018). Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States. Vaccine. 36 (33), pp. 5037-5045. [Online].